X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PANACEA BIOTECH UNICHEM LAB/
PANACEA BIOTECH
 
P/E (TTM) x 32.6 142.3 22.9% View Chart
P/BV x 3.4 3.2 108.4% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 UNICHEM LAB   PANACEA BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
PANACEA BIOTECH
Mar-14
UNICHEM LAB/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs334149 224.6%   
Low Rs17482 211.4%   
Sales per share (Unadj.) Rs146.984.1 174.6%  
Earnings per share (Unadj.) Rs11.9-18.3 -65.0%  
Cash flow per share (Unadj.) Rs16.2-6.7 -241.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.183.7 125.6%  
Shares outstanding (eoy) m90.8461.25 148.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.4 126.0%   
Avg P/E ratio x21.4-6.3 -338.5%  
P/CF ratio (eoy) x15.7-17.2 -91.0%  
Price / Book Value ratio x2.41.4 175.1%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0737,074 326.2%   
No. of employees `0005.72.8 206.3%   
Total wages/salary Rs m2,5581,449 176.5%   
Avg. sales/employee Rs Th2,352.51,874.1 125.5%   
Avg. wages/employee Rs Th450.9527.0 85.6%   
Avg. net profit/employee Rs Th190.4-407.7 -46.7%   
INCOME DATA
Net Sales Rs m13,3465,154 259.0%  
Other income Rs m192100 192.3%   
Total revenues Rs m13,5385,254 257.7%   
Gross profit Rs m1,639-766 -213.9%  
Depreciation Rs m390711 54.9%   
Interest Rs m291,503 1.9%   
Profit before tax Rs m1,412-2,881 -49.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-4-6 64.9%   
Extraordinary Inc (Exp) Rs m-351,771 -2.0%   
Tax Rs m29317 1,742.3%   
Profit after tax Rs m1,080-1,121 -96.4%  
Gross profit margin %12.3-14.9 -82.6%  
Effective tax rate %20.7-0.6 -3,554.0%   
Net profit margin %8.1-21.8 -37.2%  
BALANCE SHEET DATA
Current assets Rs m5,9793,810 156.9%   
Current liabilities Rs m2,4328,365 29.1%   
Net working cap to sales %26.6-88.4 -30.1%  
Current ratio x2.50.5 539.8%  
Inventory Days Days63156 40.5%  
Debtors Days Days6067 89.8%  
Net fixed assets Rs m6,40314,480 44.2%   
Share capital Rs m18261 296.4%   
"Free" reserves Rs m9,293903 1,029.0%   
Net worth Rs m9,5485,127 186.2%   
Long term debt Rs m2305,832 4.0%   
Total assets Rs m12,84319,433 66.1%  
Interest coverage x50.0-0.9 -5,458.9%   
Debt to equity ratio x01.1 2.1%  
Sales to assets ratio x1.00.3 391.8%   
Return on assets %8.62.0 439.7%  
Return on equity %11.3-21.9 -51.7%  
Return on capital %14.33.6 394.2%  
Exports to sales %29.224.5 119.2%   
Imports to sales %6.310.2 62.3%   
Exports (fob) Rs m3,9001,264 308.6%   
Imports (cif) Rs m847525 161.3%   
Fx inflow Rs m4,3561,539 283.0%   
Fx outflow Rs m1,162942 123.4%   
Net fx Rs m3,194597 534.8%   
CASH FLOW
From Operations Rs m1,119599 186.8%  
From Investments Rs m-853-438 194.9%  
From Financial Activity Rs m-334-303 110.4%  
Net Cashflow Rs m-68-141 48.3%  

Share Holding

Indian Promoters % 50.1 74.5 67.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.6 2,516.7%  
FIIs % 3.0 1.3 230.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.6 134.3%  
Shareholders   20,176 10,259 196.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   NATCO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare UNICHEM LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 18, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS